Figures
Abstract
Objective
The present study investigated the prevalence and risk factors for Metabolic syndrome. We evaluated the association between single nucleotide polymorphisms (SNPs) in the apolipoprotein APOA1/C3/A4/A5 gene cluster and the MetS risk and analyzed the interactions of environmental factors and APOA1/C3/A4/A5 gene cluster polymorphisms with MetS.
Methods
A study on the prevalence and risk factors for MetS was conducted using data from a large cross-sectional survey representative of the population of Jilin Province situated in northeastern China. A total of 16,831 participations were randomly chosen by multistage stratified cluster sampling of residents aged from 18 to 79 years in all nine administrative areas of the province. Environmental factors associated with MetS were examined using univariate and multivariate logistic regression analyses based on the weighted sample data. A sub-sample of 1813 survey subjects who met the criteria for MetS patients and 2037 controls from this case-control study were used to evaluate the association between SNPs and MetS risk. Genomic DNA was extracted from peripheral blood lymphocytes, and SNP genotyping was determined by MALDI-TOF-MS. The associations between SNPs and MetS were examined using a case-control study design. The interactions of environmental factors and APOA1/C3/A4/A5 gene cluster polymorphisms with MetS were assessed using multivariate logistic regression analysis.
Results
The overall adjusted prevalence of MetS was 32.86% in Jilin province. The prevalence of MetS in men was 36.64%, which was significantly higher than the prevalence in women (29.66%). MetS was more common in urban areas (33.86%) than in rural areas (31.80%). The prevalence of MetS significantly increased with age (OR = 8.621, 95%CI = 6.594–11.272). Mental labor (OR = 1.098, 95%CI = 1.008–1.195), current smoking (OR = 1.259, 95%CI = 1.108–1.429), excess salt intake (OR = 1.252, 95%CI = 1.149–1.363), and a fruit and dairy intake less than 2 servings a week were positively associated with MetS (P<0.05). A family history of diabetes (OR = 1.630, 95%CI = 1.484–1.791), cardiovascular disease or cerebral diseases (OR = 1.297, 95%CI = 1.211–1.389) was associated with MetS. APOA1 rs670, APOA5 rs662799 and rs651821 revealed significant differences in genotype distributions between the MetS patients and control subjects. The minor alleles of APOA1 rs670, APOA5 rs662799 and rs651821, and APOA5 rs2075291 were associated with MetS (P<0.0016). APOA1 rs5072 and APOC3 rs5128, APOA5 rs651821 and rs662799 were in strong linkage disequilibrium to each other with r2 greater than 0.8. Five haplotypes were associated with an increased risk of MetS (OR = 1.23, 1.58, 1.80, 1.90, and 1.98). When we investigated the interactions of environmental factors and APOA1/C3/A4/A5 gene cluster gene polymorphisms, we found that APOA5 rs662799 had interactions with tobacco use and alcohol consumption (PGE<0.05).
Conclusions
There was a high prevalence of MetS in the northeast of China. Male gender, increasing age, mental labor, family history of diabetes, cardiovascular disease or cerebral diseases, current smoking, excess salt intake, fruit and dairy intake less than 2 servings a week, and drinking were associated with MetS. The APOA1/C3/A4/A5 gene cluster was associated with MetS in the Han Chinese. APOA5 rs662799 had interactions with the environmental factors associated with MetS.
Citation: Wu Y, Yu Y, Zhao T, Wang S, Fu Y, Qi Y, et al. (2016) Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome. PLoS ONE 11(1): e0147946. https://doi.org/10.1371/journal.pone.0147946
Editor: Huiping Zhang, Yale University, UNITED STATES
Received: September 17, 2015; Accepted: January 11, 2016; Published: January 29, 2016
Copyright: © 2016 Wu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper.
Funding: This research was supported by grant 2011Z116 from the scientific research foundation of Jilin Provincial Health Department, China.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Metabolic syndrome (MetS) is a cluster of metabolic abnormalities that includes central obesity, high levels of triglycerides and glucose, low levels of high density lipoprotein, and elevated blood pressure [1]. MetS increases the risk of cardiovascular disease (CVD) and coronary artery disease (CAD) and serves as a risk factor for stroke [2–6].
The prevalence of MetS in the Chinese population was recently reported [7], especially in the south areas of China such as Jiangsu [8] and Zhejiang provinces [9] and in economic booming areas such as Beijing [10]. Jilin province is an underdeveloped area located in northeastern China that covers 780,000 square kilometers. For our study, we collected more than 16,000 samples from nine areas of Jilin province and investigated the prevalence and risk factors for MetS in Jilin province.
Several single nucleotide polymorphisms (SNPs) in different candidate genes (i.e., adipokine, lipoprotein, inflammation, adipose distribution, and glucose or energy metabolism candidate genes) have been associated with MetS [11]. Among these candidate genes, the Apolipoprotein APOA1/C3/A4/A5 gene cluster on chromosome 11q23 is a lipoprotein candidate gene cluster that plays roles in plasma triglyceride metabolism and lipoprotein lipase activity [12–14].
Rs670 at APOA1 is associated with higher HDL-C levels and higher diastolic or systolic blood pressure levels [15,16]. APOC3 rs2854117 is associated with fatty liver and postprandial plasma TG [17,18]. APOA4 has been reported to participate in lipoprotein lipase and lecithin cholesterol acyltransferase activity [19,20]. Rs5104 is not only a missense SNP but also a tag SNP at APOA4. APOA5 rs662799 is correlated with dyslipidemia and postprandial lipoprotein metabolism [21–24]. According to several studies, APOA5 rs662799 is associated with increased triglycerides, decreased HDL levels and MetS prevalence among Japanese individuals; however, no association between this SNP and MetS among Germans and Australians has been found [25,26].
In our study, we chose tag and well-studied SNPs located in the APOA1/C3/A4/A5 gene cluster. Then, we tested the association of these SNPs with MetS in the Han Chinese population using a case-control study design and evaluated the interactions of environmental factors and APOA1-APOC3-APOA4-APOA5 gene cluster polymorphisms with MetS.
Materials and Methods
Study population
This prevalence and risk factors study was conducted through a cross-sectional and representative survey of Jilin province, China. The study was designed to evaluate the prevalence and risk factors associated with chronic diseases [27]. The participants were randomly chosen from a multistage stratified cluster sampling of residents aged from 18 to 79 years in nine areas of Jilin province (both urban and rural areas) in 2012. In the first stage, the province was stratified into 9 regions, which cover all of Jilin Province. In the second stage, clusters of 4 districts or counties were randomly selected from each of the 9 regions using probability proportional to size (PPS) sampling. In the third stage, each selected district or county was divided into urban and rural areas as defined by the National Bureau of Statistics of China. Subsequently 4 or 5 communities were sampled from both rural and urban strata using PPS. Finally, 1 adult resident was randomly selected from each household of the selected communities. The loss of sampling was replaced only once. The response rate was 84.9%. A total of 16,831 participants (including 7,782 men and 9,109 women with an average age of 48 ± 13 years) who provided complete data for the variables of metabolic syndrome components were selected for this cross-sectional survey.
For the association and interaction study, 1,813 case subjects were randomly chosen using the SPSS by a method of simple random sampling from the patients with MetS in the survey above. Control subjects that were not affected with MetS were chosen from the same population that was surveyed for MetS at the same time. Both cases and controls were from the Han population in Northern China.
All subjects in this study signed a written informed consent form. Our study was approved by the ethics committee of the School of Public Health, Jilin University.
Procedures, measurements, and quality control
All selected subjects were informed by the local health service centers using reservation cards prior to the beginning of the survey. Data were collected through face-to-face questionnaire interviews as well as anthropometry and laboratory examinations.
All interviews used the same structured questionnaire and were administered by well-trained investigators. The identification of the participants was checked prior to the interview, and the completeness of the questionnaire was checked after the interview. All participants provided informed consent. Demographic data, lifestyles, eating habits, family history, and chronic diseases were obtained by self-report. The educational levels were divided into pre-middle school, middle school, high school, and post-high school degree. The participants were employed in either manual labor in the agriculture, forestry, manufactory, and service industries or mental labor such as office clerks, government officials, professional staff in medicine and education, and full-time students. The smoking status was categorized into current smoker, former smoker, and never smoked. Participants who reported smoking at least 100 cigarettes in their lifetime and smoked either every day or on some days at the time of the survey were defined as current smokers. Participants who reported smoking at least 100 cigarettes in their lifetime and did not smoke at all at the time of the survey were defined as former smokers. Participants who reported never having smoked 100 cigarettes were defined as never smoked.
The anthropometry examinations included height, weight, waistline and hip circumference, blood pressure and heart rate. Height and weight were measured in subjects standing straight and wearing light clothing without shoes. The waistline and hip circumferences were separately measured at the level of the individual’s umbilicus and the maximum protrusion of the gluteal muscles, respectively. The instruments used for the measurements were from the same manufacturer and the same batch. The systolic and diastolic blood pressures were recorded with an average of two measurements in a sitting position after a 10-minute rest.
All subjects were asked to provide 5 mL of blood for biochemical analysis. The laboratory examinations included total cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), and fasting glucose. The blood samples were collected in the morning after an overnight fast (at least 8 hours), transported to the same laboratory under refrigeration, and then stored at −20°C. The lab finished the blood examinations within 12 hours after receiving the blood samples and provided daily quality control charts. All data were double entered and validated.
Identification of the metabolic syndrome (MetS)
The prevalence of MetS was evaluated according to the International Diabetes Federation criteria (2009). The identification of MetS was based on three or more of the following components: a) Central obesity: waist circumference ≥ 85 cm in men or ≥ 80 cm in women for Chinese subjects; b) Raised triglycerides: TG ≥ 1.7 mmol/L or undergoing treatment for hypertriglyceridemia; c) Low high-density lipoprotein levels: HDL-C < 1.04 mmol/L in men and <1.30 mmol/L in women or undergoing treatment; d) Elevated blood pressure: systolic blood pressure ≥ 135 mmHg, diastolic blood pressure ≥ 85 mmHg, or the use of antihypertensive drug therapy; and e) Raised glucose: fasting glucose ≥ 5.6 mmol/L or the use of antidiabetic drugs.
SNP selection
Tag SNPs were selected using the Haploview program (http://hapmap.ncbi.nlm.nih.gov/). Three tag SNPs (APOA1 rs5072, APOC3 rs5128, and APOA5 rs2075291) were obtained. Other well-studied or functional SNPs were selected based on previous studies that documented associations between SNPs in the Apolipoprotein APOA1/C3/A4/A5 gene cluster and MetS or its components, including APOA1 rs670, APOC3 rs2854117, APOA4 rs5104, APOA5 rs662799, and APOA5 rs651821. The minor allele frequency (MAF) of the above eight SNPs was greater than 0.05 in the Chinese Han population.
DNA extraction and genotyping rate
Peripheral blood samples were collected in the morning using non-anticoagulant plexiglass tubes and stored at −20°C. Genomic DNA was extracted from peripheral blood lymphocytes using a commercial DNA extraction kit (Hangzhou, China). SNP genotyping was determined by MALDI-TOF-MS (Sequenom, San, Diego, CA, USA) using the MassARRAY system. Completed genotyping reactions were dispensed onto a 384-well spectro CHIP using a MassARRAY Nanodispenser (Sequenom)[28].
The detection rates for the SNPs APOA1 rs670 and rs5072, APOC3 rs5128 and rs2854117, APOA4 rs5104, APOA5 rs662799 and rs651821, and APOA5 rs2075291 were 91.4%, 99.7%, 99.6%, 98.3%, 95.8%, 99.1%, 99.6%, and 95.9%, respectively.
Statistical analysis
The statistical analyses were conducted using the SPSS system (version 19.0). The prevalence of MetS was adjusted by a complex weighted computation with the gender, age and location distribution according to the sixth Chinese National Population Census, 2010 [29].
Rao-Scott χ2 test was used to compare the prevalence of MetS between different genders and locations. MetS risk factors were examined using uni- and multivariate logistic regression analyses based on the complex weighted computation. The minor allele frequency of the SNPs was compared between subjects with and without MetS using the χ2 test. For each SNP, the Hardy-Weinberg disequilibrium (HWD) test was conducted in the control group. Associations between the SNPs and MetS were examined by multiple logistic regression analyses after adjusting for age and gender. There were four different models of inheritance in our study. G and A represent a pair of alleles. If A is a minor allele, the dominant model indicates GG vs AG+AA, the recessive model indicates AA vs AG+GG, the codominant model indicates GG vs GA vs AA, and the overdominant or super dominant model indicates GG + AA vs GA. The best model of inheritance for the SNPs was selected based on the Akaike information criterion (AIC), the Haplotype estimation and association were using the SNPStats program (http://bioinfo.iconcologia.net/SNPStats) [30], and the model with the minimum AIC value was the best model. A Bonferroni correction was used to account for multiple statistical tests for each SNP association. A P<0.05/32 = 0.0016 was selected as the appropriate significance level.
The interactions between environmental factors and APOA1-APOC3-APOA4-APOA5 gene cluster gene polymorphism with MetS were assessed using multivariate logistic regression analysis. For positive interaction findings the online software Quanto was used to estimate statistical power (http://hydra.usc.edu/GxE/).
Results
The Prevalence of MetS
A total of 16,831 participants were included in the study. The participants ranged in age from 18–79 years with a mean age of 48 years (SD = 13). A total of 15,492 (92.0%) of the participants were Han people. The participants came from rural (48.6%) and urban (51.4%) areas across Jilin Province.
Table 1 showed that the overall prevalence of MetS was 32.86% (SE = 0.44%). The prevalence of MetS in men was 36.64% (SE = 2.30%), which was significantly higher than the prevalence in women of 29.66% (SE = 0.59%). However, the prevalence of Mets was higher in women than in men in the age groups 55–64 and 65–79 years old. MetS was significantly more common in the urban areas than in the rural areas (P < 0.05). Regardless of whether the comparisons were made between the male and female groups or the urban and rural groups, the prevalence of MetS significantly increased with age.
Factors associated with MetS
The uni- and multivariate logistic regression analysis results are shown in Table 2. Women had a higher prevalence of MetS than men. An older age, low educational level, retirement or unemployment, former smoker, higher dietary meat intake, excess salt intake, and fruit and dairy intake less than two servings a week were positively associated with MetS. People with a family history of diabetes, cardiovascular or cerebral diseases had a higher risk of MetS (P < 0.05).
Allele frequency comparisons
The distributions of eight SNPs (APOA1 rs670 and rs5072, APOC3 rs5128 and rs2854117, APOA4 rs5104, APOA5 rs662799 and rs651821, and APOA5 rs2075291) were in Hardy-Weinberg equilibrium (HWE) in the non-MetS group. The comparisons of genotype distributions and allele frequencies of the polymorphisms in the APOA1/C3/A4/A5 gene cluster between subjects with and without MetS are shown in Table 3. Three SNPs (APOA1 rs670, APOA5 rs662799 and rs651821) revealed significant differences in genotype distributions between subjects with and without MetS. The frequencies of the APOA5 rs651821 C allele, APOA5 rs662799 G allele, and APOA5 rs2075291 T allele were significantly higher in the non-MetS group compared to the MetS group (P < 0.001). However, allele frequency differences between the MetS and the non-MetS groups were not observed for APOA1rs5072, APOC3 rs5128 and rs2854117, and APOA4 rs5104.
Genotype distribution comparison
Table 4 shows the multiple logistic regression analysis results of the best selected model after adjusting for the confounding factors age and gender. Inheritance modeling suggested an overdominant model for APOA1 rs5072, APOC3 rs5128, and APOA4 rs5104, a dominant model for APOC3 rs2854117 and APOA5 rs2075291, and a codominant model for APOA1 rs670, APOA5 rs651821, and APOA5 rs662799. The genotypes of APOA1 rs670, APOC3 rs5128, APOA5 rs662799 and rs651821, and APOA5 rs2075291 were associated with MetS (P <0.0016).
Linkage disequilibrium (LD) and haplotype analyses
The pattern of pairwise linkage disequilibrium (LD) between the SNPs among APOA1/C3/A4/A5 gene cluster was shown in Fig 1. APOA1 rs5072 and APOC3 rs5128, APOA5 rs651821 and rs662799 were in strong linkage disequilibrium to each other with r2 greater than 0.8.
The color scale ranges from red to white (color intensity decreases with decreasing r2 value). This plot was generated by Haploview (version 4.1).
The haplotype analysis identified five risk haplotypes that were significantly associated with an increased risk of MetS (OR = 1.23, 1.58, 1.80, 1.90, and 1.98) (Table 5).
Interaction analysis
We used portions of the positive variables from the risk factors study as the environmental variables and the haplotype from the association study as the gene variables. Only APOA5 rs662799 had interactions with tobacco use and alcohol consumption (PEG<0.05). APOA5 rs662799 had a positive interaction with tobacco use or alcohol consumption (OREG = 3.54) (Table 6).
Discussion
Our study was a community-based cross-sectional study with a large representative sample in Jilin Province, northeast China. The prevalence of MetS using the IDF definition in Jilin Province was 32.9% (SE = 0.4%). This prevalence was lower than the prevalence reported in the U.S. (39.0%) [31] and European (35.0% for men and 34.1% for women from the DECODE Study Group) populations [32]. The prevalence of MetS in Jilin Province was the same as the prevalence in Koreans (32.5% for men and 31.8% for women over 30 years of age) [33] but was higher than in the prevalence in the Japanese population (13.9%) [34]. The prevalence of MetS in Jilin Province was also higher than the prevalence in southern China reported for Jiangsu Province (30.5%)[8], Guangdong Province (26.7%)[35], and Taiwan (14.3%) [36]. Compared with the results from another epidemiological survey of MetS in Songyuan (an area of Jilin province) in 2010 [37], our study also showed a trend of increased prevalence of MetS in Jilin province (from 22.4% in 2009 to 32.86% at present).
In most published studies, women had a similar or a much higher prevalence of MetS than men [31,32,34,35]. In the present study, the prevalence of MetS was higher in men than in women except in the age groups 55–64 and 65–79. This discrepancy may be due to a higher prevalence of obesity, hypertension, low HDL-cholesterol and high TG levels in men compared to women prior to the age of 55. After 55 years of age, menopausal or postmenopausal women produced less estrogen, leading to changes in metabolism. The univariate logistic regression analysis results suggested that the prevalence of MetS among individuals in urban areas was much higher than the prevalence in rural areas. One possible explanation for this finding was that the prevalence of obesity and low HDL-cholesterol were higher in the urban areas. Additionally, the results indicated that age was positively associated with the MetS risk, possibly because the prevalence of hypertension, diabetes and dyslipidemia increased with age.
The multivariate logistic regression analysis results suggested that poor education and retirement or unemployment were associated with MetS. The level of education can impact an individual’s cognitive status; thus, individuals employed in a mental labor field may have a higher level of education and an increased awareness of the disease.
In the present study, alcohol consumption did not show a significant effect on MetS based on the multivariate logistic regression. However, the univariate logistic regression analysis demonstrated an impact of alcohol consumption on the risk of MetS. One possible explanation for the inconsistent result is that alcohol consumption influences the risk of MetS in a gender-specific manner. Current smoking did not have a significant effect on MetS in the multivariate logistic regression analysis; however, former smoking did have a significant effect. One explanation for this results is that individuals with chronic diseases such as hypertension may have given up smoking.
The relationship between nutrition intake and MetS has been well established. Our results indicated that daily excess, high meat intake, and excess salt intake were associated with the risk of MetS by increasing risk components of MetS such as central obesity, dyslipidemia or hypertension. In our study, a dairy intake of less than 2 servings a week was a risk factor for MetS. This result concurred with findings from Mexican, European, and Middle Eastern populations in which individuals with a higher dairy consumptions had a lower prevalence of MetS [38,39][40][41]
Genes correct physiological processes. Their expression patterns may result in metabolic abnormalities that contribute to disease processes. Family history may reflect genetic susceptibility to the disease. As a result, a family history of specific diseases, such as cardiovascular disease, cerebral diseases, and diabetes, can have an effect on MetS by influencing MetS components.
Previous studies demonstrated that SNPs located in the APOA1/C3/A4/A5 gene cluster were associated with metabolic syndrome (MetS), insulin resistance, and cardiovascular disease in several ethnic populations [42]. However, the contribution of these SNPs to MetS in the Han Chinese is unknown.
APOA1 encodes apolipoprotein A-I, which is the major protein constituent of high density lipoprotein (HDL)[43]. Mounting evidence suggests that APOA1 influences plasma lipoprotein levels [44]. In the present study, we found that the frequency of the APOA1 rs670 A allele was higher in the Chinese Han population than in populations from western countries [45]. However, the frequency of the APOA1 rs670 A allele did not significantly differ between the MetS group and non-MetS group. Several studies showed that the A allele of APOA1 rs670 was associated with HDL-C levels and that the association was either gender- or age-dependent [46,47]. The present study showed that subjects carrying the GA and AA genotypes of APOA1 rs670 had an increased risk of developing MetS compared to subjects with the GG genotype (P < 0.001). Rs5072 was a tag SNP in APOA1 with a MAF of 0.363 in the Han Chinese. In another study, APOA1 rs5072 was associated with MetS in South Asian immigrants in the USA [48]. For this SNP, our data suggested an overdominant model of inheritance. After a Bonferroni correction, rs5072 was not associated with MetS (adjusted OR = 1.19; 95% CI, 1.05–1.35; P = 0.007). The Bonferroni method is the most conservative correction for multiple comparisons of SNPs but comes at the cost of increasing the probability of producing false negatives and consequently reducing the statistical power.
APOC3, which is synthesized by the liver and intestine, is an important marker of TG-rich lipoproteins levels [49]. A previous study showed that the overexpression of the APOC3 gene resulted in higher triglyceride levels [50]. Moreover, APOC3 was transcriptionally down-regulated by insulin levels [51]. Several studies revealed that APOC3 rs5128 was associated with increased plasma TG levels [23,52,53]. The frequency of the APOC3 rs5128 G allele in our study subjects was higher than that of Indian and Japanese populations [54,55]. The distribution of the G or C allele of rs5128 was not significantly different between the MetS group and the non-MetS group. Inheritance modeling suggested an overdominant model for APOC3 rs5128. Subjects with the rs5128 genotype GC had an increased risk of MetS compared to subjects carrying the GG or CC rs5128 genotypes. Although previous studies demonstrated that APOC3 rs2854117 was associated with fatty liver and postprandial plasma TG levels [17,56], we did not observe significant differences in either the allele frequency or the genotype distribution of APOC3 rs2854117 between the MetS group and the non-MetS group in the present study.
APOA4 is a potent activator of lecithin-cholesterol acyltransferase in vitro. The APOA4 gene (APOA4) contains three exons and two introns. Because the function of APOA4 is unclear, few studies have examined the association of polymorphisms in APOA4 with MetS. Rs5104 in APOA4 was the only tag SNP with a MAF greater than 0.05 in the Han Chinese. In the present study, the allele frequencies of APOA4 rs5104 were not significantly different between subjects with and without MetS, and the rs5104 genotype was not associated with MetS after a Bonferroni correction.
The APOA5 gene is the newest identified member in the APOA1/C3/A4/A5 gene cluster region by Pennacchio et al. and van der Vliet et al. [57,58]. APOA5 variants have been associated with triglyceride, HDL-C, and total plasma cholesterol levels [59]. Among the eight SNPs, APOA5 rs662799 was the most widely studied in recent years. Several studies demonstrated either a gender- or ethnic-specific association of this SNP with MetS [26,60]. One meta-analysis showed that individuals in European and Chinese populations with the C allele of APOA5 rs662799 had a 33% and 40% increased risk of developing MetS, respectively [61]. In our study, the frequency of the C allele of APOA5 rs662799 in MetS patients was significantly higher than the frequency in the control subjects. We found that carriers of the CT genotype of rs662799 had a 1.38-fold increased risk of developing MetS compared to subjects with genotype TT and that carriers of the CC genotype of this SNP had a 2.26-fold increased risk of developing MetS compared to subjects with genotype TT. We also found that the TC and TT genotypes of rs651821 and the GG or TT genotype of rs2075291 were associated with an increased risk of MetS. Moreover, APOA5 rs651821 was found to be in strong linkage disequilibrium with APOA5 rs662799. Yin et al. reported that the APOA1/C3/A5 haplotypes were associated with serum lipid levels in a Chinese population [12]. The results from another study suggested that two haplotypes of the APOA1/C3/A5 gene cluster were associated with an increased risk of hypertriglyceridemia in a Taiwanese population [13]. However, the associations between haplotypes of the APOA1/C3/A4/A5 gene cluster and MetS have not been examined in the Chinese population. In our study, five distinct haplotypes (haplotypes 2, 4, 6, 9, and 12; Table 5) from the 12 haplotypes of the APOA1/C3/A4/A5 gene cluster were significantly associated with the risk of MetS in the Han Chinese population. Our results suggested that haplotypes 6, 9, and 12 were stronger predictive factors for MetS. These three haplotypes all contained the same alleles of APOA5 rs651821 and rs662799. It is possible that the SNPs in APOA5 may have a larger effect on the susceptibility to MetS.
One interesting finding in our study was the interaction effect of APOA5 rs662799 between tobacco use or alcohol consumption. APOA5 rs662799 had a positive interaction with tobacco use or alcohol consumption whether in additive model or multiplitive model. The power of our case/control samples based on 1807/2043 sample size to detect G×E interactions was estimated more than 60.15%. In another study, researchers found that group with the APOA5 rs662799 CT and CC genotypes showed higher levels of TG than the group of TT genotype in the ex-smokers and current smokers, but not in the non-smokers [62], and TG level was one of the components of MetS. Other studies found that drinking were positive associated with HDL-C and TG [63,64]. RX Yin [65] and colleagues found that APOA5 rs662799 had interaction effect with alcohol consumption on serum lipid levels. These interactions may contribute to the interaction effect between APOA5 rs662799 and alcohol consumption on MetS. According to our result, cutting out smoking and drinking could be recommended in the people with CT and CC genotypes of APOA5 rs662799.
The innovations of this study include: a) the participants in the association study were recruited from the community-based population; therefore, the data can be applicable to the general population and b) the sample size was sufficiently large in our study to ensure that we obtained strong statistical power. Our study also had some limitations. The prevalence of MetS was determined using a cross-sectional survey. Therefore, although the results in our study may not accurately reflect the causal relationship between the risk factors and MetS, they provided information on the association between them. In this study, the information obtained concerning the subjects’ diets was not sufficient to discuss the relationship between the diet and MetS. We selected only tag SNPs with a MAF greater than 0.05 in the Han Chinese and SNPs reported in published articles. Therefore, we may have neglected some functional SNPs in the APOA1/C3/A4/A5 gene cluster. We found that APOA5 rs662799 had a positive interaction with tobacco use or alcohol consumption (OREG = 3.54). Therefore, interventions in smoking behavior and alcohol consumption should be designed for people who carry the genotypes AG+GG.
Conclusions
In summary, there was a high prevalence of MetS in the northeast of China. The risk of MetS increased significantly with age. The male gender, lower education, retirement or unemployment, former smoker, higher dietary meat intake, excess salt intake, fruit or dairy intake less than 2 servings a week, and a family history of diabetes, cardiovascular or cerebral diseases were positively associated with MetS. The results presented here showed that the APOA1/C3/A4/A5 gene cluster was associated with MetS. APOA5 rs662799 had interactions with the environmental factors that contributed to MetS.
Acknowledgments
We are grateful to the Jilin Provincial Health Department and the Chinese Jilin Provincial Center for Disease Control and Prevention for supporting our project.
Author Contributions
Conceived and designed the experiments: YHW CGK YQY. Performed the experiments: YHW SBW YLF YQ GY WWY YYS YM JPS. Analyzed the data: YHW TCZ. Wrote the paper: YHW CGK JJ.
References
- 1. Alberti KG, Zimmet P, Shaw J, Group IDFETFC (2005) The metabolic syndrome—a new worldwide definition. Lancet 366: 1059–1062. pmid:16182882
- 2. Kazlauskiene L, Butnoriene J, Norkus A (2015) Metabolic syndrome related to cardiovascular events in a 10-year prospective study. Diabetol Metab Syndr 7: 102. pmid:26594246
- 3. Ma X, Zhu S (2013) Metabolic syndrome in the prevention of cardiovascular diseases and diabetes—still a matter of debate? Eur J Clin Nutr 67: 518–521. pmid:23403882
- 4. Stevenson JE, Wright BR, Boydstun AS (2012) The metabolic syndrome and coronary artery disease: a structural equation modeling approach suggestive of a common underlying pathophysiology. Metabolism 61: 1582–1588. pmid:22626764
- 5. Janczura M, Bochenek G, Nowobilski R, Dropinski J, Kotula-Horowitz K, Laskowicz B, et al. (2015) The Relationship of Metabolic Syndrome with Stress, Coronary Heart Disease and Pulmonary Function—An Occupational Cohort-Based Study. PLoS One 10: e0133750. pmid:26274823
- 6. Liu L, Zhan L, Wang Y, Bai C, Guo J, Lin Q, et al. (2015) Metabolic syndrome and the short-term prognosis of acute ischemic stroke: a hospital-based retrospective study. Lipids Health Dis 14: 76. pmid:26199022
- 7. Cheng TO (2007) Prevalence of metabolic syndrome is still underestimated in the Chinese population. Int J Cardiol 116: 257–258. pmid:16828904
- 8. Zuo H, Shi Z, Hu X, Wu M, Guo Z, Hussain A (2009) Prevalence of metabolic syndrome and factors associated with its components in Chinese adults. Metabolism 58: 1102–1108. pmid:19481771
- 9. Chen B, Yang D, Chen Y, Xu W, Ye B, Ni Z (2010) The prevalence of microalbuminuria and its relationships with the components of metabolic syndrome in the general population of China. Clin Chim Acta 411: 705–709. pmid:20138167
- 10. Yin JH, Song ZY, Shan PF, Xu J, Ye ZM, Xu XH, et al. (2012) Age- and gender-specific prevalence of carotid atherosclerosis and its association with metabolic syndrome in Hangzhou, China. Clin Endocrinol (Oxf) 76: 802–809.
- 11. Shim U, Kim HN, Sung YA, Kim HL (2014) Pathway Analysis of Metabolic Syndrome Using a Genome-Wide Association Study of Korea Associated Resource (KARE) Cohorts. Genomics Inform 12: 195–202. pmid:25705158
- 12. Yin RX, Li YY, Lai CQ (2011) Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels. Lipids Health Dis 10: 140. pmid:21854571
- 13. Chien KL, Fang WH, Wen HC, Lin HP, Lin YL, Lin SW, et al. (2008) APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese. Clin Chim Acta 390: 56–62. pmid:18206649
- 14. Ding Y, Zhu MA, Wang ZX, Zhu J, Feng JB, Li DS (2012) Associations of Polymorphisms in the Apolipoprotein APOA1-C3-A5 Gene Cluster with Acute Coronary Syndrome. Journal of Biomedicine and Biotechnology.
- 15. Chhabra S, Narang R, Lakshmy R, Das N (2005) APOA1-75 G to A substitution associated with severe forms of CAD, lower levels of HDL and apoA-I among northern Indians. Dis Markers 21: 169–174. pmid:16403951
- 16. Coban N, Onat A, Guclu-Geyik F, Komurcu-Bayrak E, Can G, Erginel-Unaltuna N (2014) Gender-specific associations of the APOA1 -75G>A polymorphism with several metabolic syndrome components in Turkish adults. Clin Chim Acta 431: 244–249. pmid:24508624
- 17. Hosseini-Esfahani F, Mirmiran P, Daneshpour MS, Mehrabi Y, Hedayati M, Soheilian-Khorzoghi M, et al. (2015) Dietary patterns interact with APOA1/APOC3 polymorphisms to alter the risk of the metabolic syndrome: the Tehran Lipid and Glucose Study. Br J Nutr 113: 644–653. pmid:25653052
- 18. Petersen KF, Dufour S, Hariri A, Nelson-Williams C, Foo JN, Zhang XM, et al. (2010) Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N Engl J Med 362: 1082–1089. pmid:20335584
- 19. Goldberg IJ, Scheraldi CA, Yacoub LK, Saxena U, Bisgaier CL (1990) Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV. J Biol Chem 265: 4266–4272. pmid:2307668
- 20. Steinmetz A, Utermann G (1985) Activation of lecithin: cholesterol acyltransferase by human apolipoprotein A-IV. J Biol Chem 260: 2258–2264. pmid:3918999
- 21. Povel CM, Boer JM, Reiling E, Feskens EJ (2011) Genetic variants and the metabolic syndrome: a systematic review. Obes Rev 12: 952–967. pmid:21749608
- 22. Moreno R, Perez-Jimenez F, Marin C, Moreno JA, Gomez P, Bellido C, et al. (2006) A single nucleotide polymorphism of the apolipoprotein A-V gene -1131T>C modulates postprandial lipoprotein metabolism. Atherosclerosis 189: 163–168. pmid:16386743
- 23. Liu ZK, Hu M, Baum L, Thomas GN, Tomlinson B (2010) Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese. Atherosclerosis 208: 427–432. pmid:19732897
- 24. Kao JT, Wen HC, Chien KL, Hsu HC, Lin SW (2003) A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia. Human Molecular Genetics 12: 2533–2539. pmid:12915450
- 25. Yamada Y, Kato K, Hibino T, Yokoi K, Matsuo H, Segawa T, et al. (2007) Prediction of genetic risk for metabolic syndrome. Atherosclerosis 191: 298–304. pmid:16806226
- 26. Son KY, Son HY, Chae J, Hwang J, Jang S, Yun JM, et al. (2015) Genetic association of APOA5 and APOE with metabolic syndrome and their interaction with health-related behavior in Korean men. Lipids Health Dis 14: 105. pmid:26365620
- 27. Wang S, Kou C, Liu Y, Li B, Tao Y, D'Arcy C, et al. (2015) Rural-urban differences in the prevalence of chronic disease in northeast China. Asia Pac J Public Health 27: 394–406. pmid:25246500
- 28. Gu Y, Yu Y, Ai L, Shi J, Liu X, Sun H, et al. (2014) Association of the ATM gene polymorphisms with papillary thyroid cancer. Endocrine 45: 454–461. pmid:23925578
- 29.
Office for the Sixth Population Census of Jilin Province, Jilin Provincial Bureau of Statistics (2012) Tabulation on the 2010 population census of Jilin province. Beijing: China Statistics Press, (in Chinese).
- 30. Sole X, Guino E, Valls J, Iniesta R, Moreno V (2006) SNPStats: a web tool for the analysis of association studies. Bioinformatics 22: 1928–1929. pmid:16720584
- 31. Ford ES (2005) Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 28: 2745–2749. pmid:16249550
- 32. Qiao Q, Group DS (2006) Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia 49: 2837–2846. pmid:17021922
- 33.
Korea Health Industry Development Institute (2005) The Third Korea National Health and Nutrition Examination Survey (KNHANES III). Seoul: Ministry of Health and Welfare Press
- 34. Group DS (2007) Prevalence of the metabolic syndrome in populations of Asian origin. Comparison of the IDF definition with the NCEP definition. Diabetes Res Clin Pract 76: 57–67. pmid:17010470
- 35. Li JB, Wang X, Zhang JX, Gu P, Zhang X, Chen CX, et al. (2010) Metabolic syndrome: prevalence and risk factors in southern China. J Int Med Res 38: 1142–1148. pmid:20819453
- 36. Hwang LC, Bai CH, Chen CJ (2006) Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Assoc 105: 626–635. pmid:16935763
- 37. Wang W, Kong J, Sun J, Wang CY, Chen HY, Jiang YF, et al. (2010) Epidemiological investigation of metabolic syndrome and analysis of relevant factors in north-eastern China. J Int Med Res 38: 150–159. pmid:20233524
- 38. Ghotboddin Mohammadi S, Mirmiran P, Bahadoran Z, Mehrabi Y, Azizi F (2015) The Association of Dairy Intake With Metabolic Syndrome and Its Components in Adolescents: Tehran Lipid and Glucose Study. Int J Endocrinol Metab 13: e25201. pmid:26425126
- 39. Fumeron F, Lamri A, Abi Khalil C, Jaziri R, Porchay-Balderelli I, Lantieri O, et al. (2011) Dairy consumption and the incidence of hyperglycemia and the metabolic syndrome: results from a french prospective study, Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 34: 813–817. pmid:21447660
- 40. Mosley MA, Andrade FCD, Aradillas-Garcia C, Teran-Garcia M (2013) Consumption of dairy and metabolic syndrome risk in a convenient sample of Mexican college applicants. Food and Nutrition Sciences 4:56–65.
- 41. Elwood PC, Pickering JE, Fehily AM (2007) Milk and dairy consumption, diabetes and the metabolic syndrome: the Caerphilly prospective study. J Epidemiol Community Health 61: 695–698. pmid:17630368
- 42. Lai CQ, Parnell LD, Ordovas JM (2005) The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk. Curr Opin Lipidol 16: 153–166. pmid:15767855
- 43. Fielding CJ, Shore VG, Fielding PE (1972) A protein cofactor of lecithin:cholesterol acyltransferase. Biochem Biophys Res Commun 46: 1493–1498. pmid:4335615
- 44. Heng CK, Low PS, Saha N (2001) Variations in the promoter region of the apolipoprotein A-1 gene influence plasma lipoprotein(a) levels in Asian Indian neonates from Singapore. Pediatr Res 49: 514–518. pmid:11264435
- 45. Mattei J, Demissie S, Tucker KL, Ordovas JM (2011) The APOA1/C3/A4/A5 cluster and markers of allostatic load in the Boston Puerto Rican Health Study. Nutr Metab Cardiovasc Dis 21: 862–870. pmid:20674306
- 46. Rudkowska I, Dewailly E, Hegele RA, Boiteau V, Dube-Linteau A, Abdous B, et al. (2013) Gene-diet interactions on plasma lipid levels in the Inuit population. Br J Nutr 109: 953–961. pmid:23021345
- 47. de Franca E, Alves JG, Hutz MH (2005) APOA1/C3/A4 gene cluster variability and lipid levels in Brazilian children. Braz J Med Biol Res 38: 535–541. pmid:15962178
- 48. Dodani S, Henkhaus R, Dong L, Butler MG (2012) Apo lipoprotein A1 gene polymorphisms predict cardio-metabolic risk in South Asian immigrants. Dis Markers 32: 9–19. pmid:22297598
- 49. Olivieri O, Bassi A, Stranieri C, Trabetti E, Martinelli N, Pizzolo F, et al. (2003) Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease. J Lipid Res 44: 2374–2381. pmid:14563827
- 50. Jong MC, Hofker MH, Havekes LM (1999) Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler Thromb Vasc Biol 19: 472–484. pmid:10073946
- 51. Chen M, Breslow JL, Li W, Leff T (1994) Transcriptional regulation of the apoC-III gene by insulin in diabetic mice: correlation with changes in plasma triglyceride levels. J Lipid Res 35: 1918–1924. pmid:7868970
- 52. Mar R, Pajukanta P, Allayee H, Groenendijk M, Dallinga-Thie G, Krauss RM, et al. (2004) Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia. Circ Res 94: 993–999. pmid:15001527
- 53. Qi L, Liu S, Rifai N, Hunter D, Hu FB (2007) Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes. Atherosclerosis 192: 204–210. pmid:16781717
- 54. Chhabra S, Narang R, Krishnan LR, Vasisht S, Agarwal DP, Srivastava LM, et al. (2002) Apolipoprotein C3 SstI polymorphism and triglyceride levels in Asian Indians. BMC Genet 3: 9. pmid:12052247
- 55. Bai H, Saku K, Liu R, Imamura M, Arakawa K (1995) Association between coronary heart disease and the apolipoprotein A-I/C-III/A-IV complex in a Japanese population. Hum Genet 95: 102–104. pmid:7814010
- 56. Salamone F, Galvano F, Li Volti G (2010) Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N Engl J Med 363: 194–195; author reply 195.
- 57. Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, et al. (2001) An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294: 169–173. pmid:11588264
- 58. van der Vliet HN, Sammels MG, Leegwater AC, Levels JH, Reitsma PH, Boers W, et al. (2001) Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. J Biol Chem 276: 44512–44520. pmid:11577099
- 59. Garelnabi M, Lor K, Jin J, Chai F, Santanam N (2013) The paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic research. Clin Biochem 46: 12–19. pmid:23000317
- 60. Komurcu-Bayrak E, Onat A, Poda M, Humphries SE, Palmen J, Guclu F, et al. (2008) Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults. Clin Chem Lab Med 46: 778–784. pmid:18601598
- 61. Song KH, Cha S, Yu SG, Yu H, Oh SA, Kang NS (2013) Association of apolipoprotein A5 gene -1131T>C polymorphism with the risk of metabolic syndrome in Korean subjects. Biomed Res Int 2013: 585134. pmid:23509746
- 62. Xu C, Bai R, Zhang D, Li Z, Zhu H, Lai M, et al. (2013) Effects of APOA5 -1131T>C (rs662799) on fasting plasma lipids and risk of metabolic syndrome: evidence from a case-control study in China and a meta-analysis. PLoS One 8: e56216. pmid:23468858
- 63. Volcik KA, Ballantyne CM, Fuchs FD, Sharrett AR, Boerwinkle E (2008) Relationship of alcohol consumption and type of alcoholic beverage consumed with plasma lipid levels: differences between Whites and African Americans of the ARIC study. Ann Epidemiol 18: 101–107. pmid:17855114
- 64. Ruidavets JB, Ducimetiere P, Arveiler D, Amouyel P, Bingham A, Wagner A, et al. (2002) Types of alcoholic beverages and blood lipids in a French population. J Epidemiol Community Health 56: 24–28. pmid:11801616
- 65. Yin RX, Li YY, Wu JZ, Pan SL, Liu CW, Lin WX, et al. (2013) Interactions between the apolipoprotein a1/c3/a5 haplotypes and alcohol consumption on serum lipid levels. Alcohol Clin Exp Res 37: 234–243. pmid:22924697